
Developing bioassay methods requires a new approach for cell and gene therapy drug development.
Benjamin Ziehr, PhD, is senior group leader at PPD Laboratories’ GMP cell lab.

Developing bioassay methods requires a new approach for cell and gene therapy drug development.

Published: July 1st 2021 | Updated: